Elixir Capital Ltd (531278)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Elixir Capital's revenue was ₹20.4 Cr (+87.0% year on year), and net profit ₹6.1 Cr (+66.3% year on year); the operating margin was 62.5%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹20.4 | +87.0% | from loss |
| Operating profit | ₹12.8 | +200.2% | from loss |
| Net profit | ₹6.1 | +66.3% | from loss |
| EPS (₹) | 10.56 | +124.7% | from loss |
| Operating margin | 62.5% | — | — |
📢 Recent Corporate Announcements
At its 32nd Annual General Meeting held on August 25, 2026, Elixir Capital Limited approved the appointment of M/s. M. Parashar & Co., Chartered Accountants, as the company's new statutory auditors. The appointment spans a 5-year tenure from the conclusion of the 32nd AGM until the 37th AGM. Outgoing auditor M/s. JMT & Associates stepped down following the completion of their statutory term. The change is a standard statutory compliance and rotation process under company law.
- Appointment approved at the 32nd AGM held on August 25, 2026
- M/s. M. Parashar & Co. appointed for a term spanning from the 32nd AGM till the 37th AGM
- Outgoing statutory auditors M/s. JMT & Associates completed their prescribed term
- Appointed audit firm M/s. M. Parashar & Co. was established in 1987 with 8 partners and ICAI peer review valid till May 2027
Elixir Capital reported a strong turnaround in Q1 FY27, with consolidated total income reaching ₹20.62 Cr, a 70.5% increase from ₹12.09 Cr in Q1 FY26. Net profit after minority interest stood at ₹6.13 Cr, a significant recovery from the ₹5.42 Cr loss reported in the preceding March 2026 quarter. The quarterly EPS of ₹10.56 is notably higher than the total TTM EPS of ₹5.22, indicating a sharp spike in profitability. The standalone entity remains largely non-operational, with almost all value driven by consolidated subsidiaries.
- Consolidated Total Income grew 70.5% YoY to ₹20.62 Cr from ₹12.09 Cr.
- Consolidated Net Profit (after minority interest) rose 125% YoY to ₹6.13 Cr.
- Quarterly EPS reached ₹10.56, compared to ₹4.70 in the same quarter last year.
- Total Consolidated Expenses increased to ₹8.45 Cr from ₹7.40 Cr YoY.
- The company reversed a significant loss of ₹5.42 Cr from the previous quarter (March 2026).
Elixir Capital reported a strong recovery in Q1 FY27 with consolidated total income reaching Rs 20.62 Cr, a 70.5% increase compared to Rs 12.09 Cr in the same quarter last year. The company achieved a consolidated net profit (after minority interest) of Rs 6.13 Cr, a significant turnaround from the Rs 5.43 Cr loss reported in the preceding quarter (March 2026). The quarterly EPS of Rs 10.56 is notably higher than the total TTM EPS of Rs 5.22, reflecting a sharp operational rebound. However, the standalone entity remains negligible, indicating that almost all value resides within its subsidiaries.
- Consolidated Total Income rose 70.5% YoY to Rs 20.62 Cr from Rs 12.09 Cr.
- Consolidated Net Profit (after minority interest) more than doubled YoY to Rs 6.13 Cr from Rs 2.73 Cr.
- Quarterly EPS stood at Rs 10.56, compared to Rs 4.70 in the year-ago period.
- Total Expenses increased moderately to Rs 8.46 Cr from Rs 7.40 Cr YoY.
- The company reversed a massive loss of Rs 5.43 Cr from the previous quarter (March 2026).
Elixir Capital Ltd has scheduled a board meeting on August 13, 2026, to approve its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. This announcement follows a challenging March 2026 quarter where the company reported a net loss of ₹7.34 cr. Investors will be looking for signs of recovery as TTM PAT stands at ₹4 cr, a significant decline from the ₹12.65 cr reported in FY25. The trading window for company securities has been closed since July 1, 2026.
- Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results
- Trading window closed from July 1, 2026, until 48 hours after result declaration
- Company reported a significant net loss of ₹7.34 cr in the previous quarter (March 2026)
- TTM Revenue of ₹34 cr is relatively small compared to the ₹88 cr market capitalization
- Promoter holding remains stable at 71.18% as of June 2026
Elixir Capital has scheduled its 32nd Annual General Meeting (AGM) for August 25, 2026, to approve a dividend of Rs 1.25 per share (12.5% on face value). The company has fixed August 18, 2026, as the record date for dividend eligibility, representing a yield of approximately 1.05% at the current price. Key agenda items include the appointment of M/s. M. Parashar & Co. as new statutory auditors for a 5-year term and the re-appointment of Mrs. Radhika Mehta as Whole Time Director for five years. This comes after a fiscal year (FY26) where net profit declined to Rs 4.1 cr from Rs 12.65 cr in FY25.
- Dividend of Rs 1.25 per equity share (12.5%) recommended for the financial year ended March 31, 2026.
- Record date for dividend eligibility set for August 18, 2026.
- Proposed appointment of M/s. M. Parashar & Co. as Statutory Auditors for a 5-year term until the 37th AGM.
- Re-appointment of Mrs. Radhika Mehta as Whole Time Director for a 5-year term starting August 14, 2026.
- AGM to be held on August 25, 2026, at 10:00 AM via Video Conferencing.
Elixir Capital has released its FY26 Annual Report and scheduled its 32nd AGM for August 25, 2026. The company recommended a dividend of Rs 1.25 per share (12.5%), totaling Rs 72.50 lakhs, which is approximately 18% of its TTM PAT. The report highlights a significant 70.51% year-on-year decline in Return on Equity (ROE) and a 67.43% drop in Net Profit Ratio, primarily attributed to adverse market conditions affecting stock valuations. Additionally, the company is proposing a change in statutory auditors to M/s. M. Parashar & Co. for a five-year term.
- Recommended dividend of Rs 1.25 per equity share (12.5%) for the financial year ended March 31, 2026.
- Total dividend payout estimated at Rs 72.50 lakhs, representing 18.1% of TTM PAT.
- Return on Equity (ROE) plummeted by 70.51% YoY, falling from 0.24 to 0.07.
- Net Profit Ratio declined by 67.43% due to sharp drops in stock valuations from market conditions.
- Proposed appointment of M/s. M. Parashar & Co. as Statutory Auditors, replacing M/s. JMT & Associates.
Elixir Capital Limited has announced a final dividend of Rs 1.25 per equity share for the financial year 2025-26, which represents a 12.5% payout on the face value. The company has fixed August 18, 2026, as the record date to identify eligible shareholders. Additionally, the 32nd Annual General Meeting (AGM) is scheduled to be held on August 25, 2026. This announcement formalizes the timeline for the dividend distribution previously recommended by the board.
- Final dividend declared at Rs 1.25 per equity share for FY 2025-26
- Dividend payout rate established at 12.5% of the face value
- Record date for dividend eligibility set for August 18, 2026
- 32nd Annual General Meeting scheduled for August 25, 2026
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.